tenethealth.com - THC Business Value to Revenue

Tenet Healthcare Corp (THC) - corporate logo

Back-office automation and AI-driven optimization of operational units are creating a new technological foundation for Tenet Healthcare (THC). The enterprise value-to-sales multiple reflects the current market valuation, where the level of 1611.34 is the current figure. The rise in share prices is supported by the expansion of the USPI network and debt reduction, while business resilience is guaranteed by regional ecosystems that integrate insurance programs and hospital networks.

Tenet (THC): EV/Sales Multiple from 11/23/2025 to 11/20/2026

Financial and market metric breakdowns for Tenet Healthcare Corporation (THC)

- issuer market value details:
Fundamental company valuation:Tenet Healthcare THC
Flagship merchandise of tenethealth.com

The EV/Sales multiple determines the total enterprise value, including net debt, per unit of revenue, allowing for an assessment of revenue generation efficiency regardless of capital structure. By analyzing the EV/Sales multiple, an investor identifies whether an asset is overbought or detects hidden risks of overvaluation prior to a potential correction. For Tenet Healthcare (THC), this indicator is critical as it reflects the company's ability to monetize outpatient demand amid strict government insurance limits.

Competitor analysis for Tenet Healthcare

Enterprise Value-to-Revenue Multiple hcahealthcare.com|FMS: EV/Sales Multiple|Company Value to Revenue Ratio SOLV|Enterprise Value-to-Revenue Ratio Encompass|EV/Sales Multiple uhsinc.com|Enterprise Value-to-Revenue Ratio DaVita (DVA)|Total Company Value-to-Revenue Ratio radnet.com|EV/Sales Multiple OPCH (optioncarehealth.com)|SGRY (Surgery Partners) - Enterprise Value to Sales Volume|PINC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio America's Best Contacts & Eyeglasses EYE|PGNY: EV/Sales Multiple|ARDT (Ardent Health Partners) - Enterprise Value-to-Revenue Ratio|SEM (selectmedical.com) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio ASTH|EV/Sales Multiple MD|Enterprise Value-to-Revenue Ratio USPH (US Physical Therapy Inc)|Enterprise Value-to-Revenue Ratio The Pennant Group, Inc. PNTG|Business Value to Revenue ORGO|NUTX - Enterprise Value-to-Revenue Ratio|AUNA - EV/Sales Multiple|SBC Medical Group Inc (SBC) - Enterprise Value-to-Revenue Ratio|EOLS: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio chs.net|SKIN: Business Value to Revenue|EV/Sales Multiple MDWD|BTMD - Enterprise Value-to-Revenue Multiple|The Joint Chiropractic - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient DCGO (DocGo, Inc)|Total Company Value-to-Revenue Ratio PIII (p3hp.org)|GANX (Gain Therapeutics) - Company Value to Revenue Ratio|euda.com (EUDA) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Basel Medical|CLGN (CollPlant Biotechnologies) - EV/Sales Multiple|EV/Sales Multiple Cuprina Holdings Limited|Enterprise Value-to-Revenue Ratio concordmedical.com (CCM)|Enterprise Value-to-Revenue Ratio AMS (American Shared Hospital)|Enterprise Value-to-Revenue Ratio MEDIROM Corp MRM|EV/Sales Multiple avalon-globocare.com ALBT|DHAI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple